4.1 Article

Zoledronic acid in the management of metastatic bone disease

Journal

Therapeutics and Clinical Risk Management
Volume Volume 4, Issue -, Pages 261-268

Publisher

Dove Medical Press Ltd.
DOI: 10.2147/tcrm.s2707

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available